In Feb26, The US FDA accepted Roches Giredestrant NDA for ESR1-mutated, ER-positive advanced breast cancer Total Revenue: $60.4B Founded Year: 1886 Total Employees: 1,38,200 Headquarters: New Jersey, United States Market Cap: $581.22B Stock Exchange: NYSE JnJ is a diversified healthcare company with a strong pharmaceuticals segment (Innovative Medicine) alongside medical devices, focusing on oncology, immunology, neuroscience, and cardiovascular diseases
Key takeaways: GLP-1 is a rapid-acting gut hormone that regulates blood sugar and appetite by signaling insulin release and suppressing glucagon
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) offer substantial cardiometabolic benefits in diabetic populations, but their effects in obese RA patients without diabetes are not well defined
Some people may also experience redness or discomfort at the injection site
Glucagon-like peptide-1 and the islet beta-cell: augmentation of cell proliferation and inhibition of apoptosis
If you are using a peptide calculator for any supportive compounds, keep precise records of dosing and timing
